デフォルト表紙
市場調査レポート
商品コード
1589003

スマートインスリンペンとポンプの世界市場

Smart Insulin Pens and Pumps


出版日
ページ情報
英文 89 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
スマートインスリンペンとポンプの世界市場
出版日: 2024年11月13日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 89 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

スマートインスリンペンとポンプの世界市場は2030年までに92億米ドルに到達

2023年に52億米ドルと推定されるスマートインスリンペンとポンプの世界市場は、分析期間2023-2030年にCAGR 8.6%で成長し、2030年には92億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるスマートインスリンポンプは、CAGR 8.1%を記録し、分析期間終了までに79億米ドルに達すると予測されます。スマートインスリンペン分野の成長率は、分析期間中CAGR 12.7%と推定されます。

米国市場は14億米ドルと推定、中国はCAGR 8.2%で成長予測

米国のスマートインスリンペンとポンプ市場は2023年に14億米ドルと推定されます。世界第2位の経済大国である中国は、2023~2030年の分析期間においてCAGR 8.2%を辿り、2030年までに14億米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ8.1%と7.1%と予測されています。欧州では、ドイツがCAGR約7.0%で成長すると予測されています。

世界のスマートインスリンペンとポンプ市場- 主要動向と促進要因のまとめ

スマートインスリンペンとポンプはどのように糖尿病管理を強化しているのか?

スマートインスリンペンとポンプは、正確なリアルタイムデータを提供し、個人に合わせたインスリン投与を行うことで、糖尿病管理を改善するように設計された先進医療機器です。スマートペンは測定された量のインスリンを供給し、スマートポンプはユーザーのグルコースレベルに基づいた持続的な皮下インスリン注入を行います。これらのデバイスは、Bluetooth接続、投与量追跡、モバイルアプリとの統合などの機能を備えており、ユーザーはインスリン使用量を正確にモニターし、調整することができます。スマートインスリンペンとポンプは、個別化治療をサポートし、合併症のリスクを低減することで、1型糖尿病患者および2型糖尿病患者の糖尿病治療を変革しています。

スマートインスリンペンとポンプ市場の主要セグメントは?

主な製品タイプには、スマートインスリンペン、スマートインスリンポンプ、コネクテッドインスリンキャップなどがあり、スマートインスリンポンプは、持続グルコースモニタリング(CGM)対応でインスリン投与を自動化できることから、最大の市場シェアを占めています。主な用途は1型糖尿病と2型糖尿病であり、1型糖尿病患者は一貫したインスリン管理を必要とするため、1型糖尿病が重要なセグメントを占めています。エンドユーザーには、病院、診療所、在宅医療が含まれ、在宅医療は糖尿病患者の自己管理ツールの採用増加により市場をリードしています。

スマートインスリンデバイスは糖尿病ケアにどのように統合されているか?

スマートインスリンペンは、投与量の記憶、投与量の推奨、投与漏れアラートを備えており、ユーザーが食事時間や補正インスリンを効果的に管理できるよう支援します。スマートポンプは、しばしば持続グルコースモニタリング(CGM)システムと統合され、グルコース測定値に基づいてインスリン投与を自動的に調整し、安定した血糖値をサポートします。病院や診療所では、これらの機器はインスリン治療の成果を向上させ、ミスを減らし、患者モニタリングのためにヘルスケア専門家にリアルタイムデータを提供するために使用されています。さらに、在宅療養患者はスマートペンやポンプと連動したモバイルアプリを使用して、インスリン使用量を追跡し、グルコース動向を確認し、個人に合わせた治療調整を受け、より良いセルフケアとアドヒアランスをサポートしています。

スマートインスリンペンとポンプ市場の成長を促進する要因は?

スマートインスリンペンとポンプ市場の成長は、糖尿病有病率の増加、より効果的なインスリン管理ソリューションへのニーズの高まりなど、いくつかの要因によって牽引されています。接続性、投与精度、CGM統合などの機器技術の進歩により、ユーザーの利便性と治療成績が向上しています。糖尿病治療における個別化医療と自己管理への注目の高まりが、スマートインスリンデバイスの採用を加速させています。デジタルヘルスと慢性疾患管理を推進する政府のイニシアティブは、患者が生活の質を向上させるための高度なソリューションを求めているため、需要をさらに促進しています。さらに、ヘルスケアプロバイダーが病院の再入院を減らし、患者の転帰を改善することに注力していることも、スマートインスリンペンとポンプの普及に寄与しています。

調査対象企業の例(注目の33社)

  • Cellenovo
  • Companion Medical Inc.
  • Emperra Gmbh E-Health Technologies
  • F Hoffmann-La Roche
  • Insulet Corporation
  • Jiangasu Delfu Medical Device Co Ltd
  • Medical Inc.
  • Medtronic Inc.
  • Novo Nordisk
  • Sooil Development
  • Tandem Diabetes Care
  • Valeritas Inc.
  • Ypsomed

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP22791

Global Smart Insulin Pens and Pumps Market to Reach US$9.2 Billion by 2030

The global market for Smart Insulin Pens and Pumps estimated at US$5.2 Billion in the year 2023, is expected to reach US$9.2 Billion by 2030, growing at a CAGR of 8.6% over the analysis period 2023-2030. Smart Insulin Pumps, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach US$7.9 Billion by the end of the analysis period. Growth in the Smart Insulin Pens segment is estimated at 12.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.4 Billion While China is Forecast to Grow at 8.2% CAGR

The Smart Insulin Pens and Pumps market in the U.S. is estimated at US$1.4 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$1.4 Billion by the year 2030 trailing a CAGR of 8.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.1% and 7.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.0% CAGR.

Global Smart Insulin Pens and Pumps Market - Key Trends and Drivers Summarized

How Are Smart Insulin Pens and Pumps Enhancing Diabetes Management?

Smart insulin pens and pumps are advanced medical devices designed to improve diabetes management by providing accurate, real-time data and personalized insulin delivery. Smart pens deliver insulin in measured doses, while smart pumps provide continuous subcutaneous insulin infusion based on the user's glucose levels. These devices offer features like Bluetooth connectivity, dose tracking, and integration with mobile apps, enabling users to monitor and adjust insulin usage with precision. By supporting personalized therapy and reducing the risk of complications, smart insulin pens and pumps are transforming diabetes care for both Type 1 and Type 2 diabetics.

What Are the Key Segments in the Smart Insulin Pens and Pumps Market?

Key product types include smart insulin pens, smart insulin pumps, and connected insulin caps, with smart insulin pumps holding the largest market share due to their continuous glucose monitoring (CGM) compatibility and ability to automate insulin delivery. Major applications cover Type 1 and Type 2 diabetes, with Type 1 diabetes representing a significant segment as these patients require consistent insulin management. End-users include hospitals, clinics, and home care, with home care leading the market due to the increasing adoption of self-management tools by diabetic patients.

How Are Smart Insulin Devices Integrated Across Diabetes Care?

Smart insulin pens are equipped with dose memory, dose recommendations, and missed dose alerts, helping users manage mealtime and correction insulin effectively. Smart pumps, often integrated with continuous glucose monitoring (CGM) systems, automatically adjust insulin delivery based on glucose readings, supporting stable blood sugar levels. In hospitals and clinics, these devices are used to improve insulin therapy outcomes, reduce errors, and provide real-time data to healthcare professionals for patient monitoring. Additionally, home care patients use mobile apps linked to smart pens and pumps to track insulin usage, review glucose trends, and receive personalized therapy adjustments, supporting better self-care and adherence.

What Factors Are Driving the Growth in the Smart Insulin Pens and Pumps Market?

The growth in the Smart Insulin Pens and Pumps market is driven by several factors, including increasing diabetes prevalence, which has heightened the need for more effective insulin management solutions. Advancements in device technology, such as improved connectivity, dose accuracy, and CGM integration, have enhanced user convenience and therapy outcomes. The rising focus on personalized medicine and self-management in diabetes care has accelerated the adoption of smart insulin devices. Government initiatives promoting digital health and chronic disease management have further fueled demand, as patients seek advanced solutions to improve quality of life. Additionally, healthcare providers’ focus on reducing hospital readmissions and improving patient outcomes has contributed to the widespread adoption of smart insulin pens and pumps.

Select Competitors (Total 33 Featured) -

  • Cellenovo
  • Companion Medical Inc.
  • Emperra Gmbh E-Health Technologies
  • F Hoffmann-La Roche
  • Insulet Corporation
  • Jiangasu Delfu Medical Device Co Ltd
  • Medical Inc.
  • Medtronic Inc.
  • Novo Nordisk
  • Sooil Development
  • Tandem Diabetes Care
  • Valeritas Inc.
  • Ypsomed

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Smart Insulin Pens and Pumps - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Diabetes Spurs Demand for Smart Insulin Pens and Pumps
    • Technological Advancements in Real-Time Glucose Monitoring and Automated Insulin Delivery Drive Adoption
    • Growing Focus on Personalized Diabetes Management Expands Addressable Market for Smart Insulin Devices
    • Expansion of Smart Insulin Solutions in Home Healthcare and Remote Patient Monitoring Fuels Market Growth
    • Increasing Demand for Accurate Dosing, Safety Alerts, and Predictive Analytics Drives Adoption
    • Integration with Mobile Apps, AI-Powered Coaching, and Data Analytics Strengthens Business Case
    • Rising Focus on Patient Adherence, Dosage Tracking, and Data-Driven Insights Accelerates Demand
    • Technological Innovations in Needle-Free Insulin Delivery and Wearable Infusion Pumps Propel Market Growth
    • Growing Use of Smart Insulin Devices in Pediatrics, Geriatrics, and Special Populations Drives Adoption
    • Focus on Achieving Seamless Integration with Telehealth Platforms Expands Addressable Market
    • Technological Advancements in Long-Lasting Battery, Compact Design, and Bluetooth Connectivity Propel Growth
    • Rising Demand for Cost-Effective, Reusable, and Disposable Smart Insulin Devices Generates Market Opportunities
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World 7-Year Perspective for Smart Insulin Pens and Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
    • TABLE 3: World Recent Past, Current & Future Analysis for Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 4: World 7-Year Perspective for Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Pens by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World 7-Year Perspective for Pens by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World 7-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 9: World Recent Past, Current & Future Analysis for Home Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 10: World 7-Year Perspective for Home Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World 7-Year Perspective for Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 13: World Smart Insulin Pens and Pumps Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Smart Insulin Pens and Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 14: USA Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by Product - Pumps and Pens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 15: USA 7-Year Perspective for Smart Insulin Pens and Pumps by Product - Percentage Breakdown of Value Sales for Pumps and Pens for the Years 2024 & 2030
    • TABLE 16: USA Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by End-Use - Hospitals & Clinics, Home Care and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 17: USA 7-Year Perspective for Smart Insulin Pens and Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care and Laboratories for the Years 2024 & 2030
  • CANADA
    • TABLE 18: Canada Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by Product - Pumps and Pens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 19: Canada 7-Year Perspective for Smart Insulin Pens and Pumps by Product - Percentage Breakdown of Value Sales for Pumps and Pens for the Years 2024 & 2030
    • TABLE 20: Canada Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by End-Use - Hospitals & Clinics, Home Care and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: Canada 7-Year Perspective for Smart Insulin Pens and Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care and Laboratories for the Years 2024 & 2030
  • JAPAN
    • Smart Insulin Pens and Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 22: Japan Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by Product - Pumps and Pens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 23: Japan 7-Year Perspective for Smart Insulin Pens and Pumps by Product - Percentage Breakdown of Value Sales for Pumps and Pens for the Years 2024 & 2030
    • TABLE 24: Japan Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by End-Use - Hospitals & Clinics, Home Care and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 25: Japan 7-Year Perspective for Smart Insulin Pens and Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care and Laboratories for the Years 2024 & 2030
  • CHINA
    • Smart Insulin Pens and Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 26: China Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by Product - Pumps and Pens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: China 7-Year Perspective for Smart Insulin Pens and Pumps by Product - Percentage Breakdown of Value Sales for Pumps and Pens for the Years 2024 & 2030
    • TABLE 28: China Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by End-Use - Hospitals & Clinics, Home Care and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 29: China 7-Year Perspective for Smart Insulin Pens and Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care and Laboratories for the Years 2024 & 2030
  • EUROPE
    • Smart Insulin Pens and Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 30: Europe Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 31: Europe 7-Year Perspective for Smart Insulin Pens and Pumps by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
    • TABLE 32: Europe Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by Product - Pumps and Pens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Europe 7-Year Perspective for Smart Insulin Pens and Pumps by Product - Percentage Breakdown of Value Sales for Pumps and Pens for the Years 2024 & 2030
    • TABLE 34: Europe Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by End-Use - Hospitals & Clinics, Home Care and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 35: Europe 7-Year Perspective for Smart Insulin Pens and Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care and Laboratories for the Years 2024 & 2030
  • FRANCE
    • Smart Insulin Pens and Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 36: France Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by Product - Pumps and Pens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 37: France 7-Year Perspective for Smart Insulin Pens and Pumps by Product - Percentage Breakdown of Value Sales for Pumps and Pens for the Years 2024 & 2030
    • TABLE 38: France Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by End-Use - Hospitals & Clinics, Home Care and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: France 7-Year Perspective for Smart Insulin Pens and Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care and Laboratories for the Years 2024 & 2030
  • GERMANY
    • Smart Insulin Pens and Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 40: Germany Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by Product - Pumps and Pens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 41: Germany 7-Year Perspective for Smart Insulin Pens and Pumps by Product - Percentage Breakdown of Value Sales for Pumps and Pens for the Years 2024 & 2030
    • TABLE 42: Germany Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by End-Use - Hospitals & Clinics, Home Care and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 43: Germany 7-Year Perspective for Smart Insulin Pens and Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care and Laboratories for the Years 2024 & 2030
  • ITALY
    • TABLE 44: Italy Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by Product - Pumps and Pens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Italy 7-Year Perspective for Smart Insulin Pens and Pumps by Product - Percentage Breakdown of Value Sales for Pumps and Pens for the Years 2024 & 2030
    • TABLE 46: Italy Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by End-Use - Hospitals & Clinics, Home Care and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 47: Italy 7-Year Perspective for Smart Insulin Pens and Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care and Laboratories for the Years 2024 & 2030
  • UNITED KINGDOM
    • Smart Insulin Pens and Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 48: UK Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by Product - Pumps and Pens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 49: UK 7-Year Perspective for Smart Insulin Pens and Pumps by Product - Percentage Breakdown of Value Sales for Pumps and Pens for the Years 2024 & 2030
    • TABLE 50: UK Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by End-Use - Hospitals & Clinics, Home Care and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: UK 7-Year Perspective for Smart Insulin Pens and Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care and Laboratories for the Years 2024 & 2030
  • REST OF EUROPE
    • TABLE 52: Rest of Europe Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by Product - Pumps and Pens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 53: Rest of Europe 7-Year Perspective for Smart Insulin Pens and Pumps by Product - Percentage Breakdown of Value Sales for Pumps and Pens for the Years 2024 & 2030
    • TABLE 54: Rest of Europe Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by End-Use - Hospitals & Clinics, Home Care and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 55: Rest of Europe 7-Year Perspective for Smart Insulin Pens and Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care and Laboratories for the Years 2024 & 2030
  • ASIA-PACIFIC
    • Smart Insulin Pens and Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by Product - Pumps and Pens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific 7-Year Perspective for Smart Insulin Pens and Pumps by Product - Percentage Breakdown of Value Sales for Pumps and Pens for the Years 2024 & 2030
    • TABLE 58: Asia-Pacific Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by End-Use - Hospitals & Clinics, Home Care and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 59: Asia-Pacific 7-Year Perspective for Smart Insulin Pens and Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care and Laboratories for the Years 2024 & 2030
  • REST OF WORLD
    • TABLE 60: Rest of World Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by Product - Pumps and Pens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 61: Rest of World 7-Year Perspective for Smart Insulin Pens and Pumps by Product - Percentage Breakdown of Value Sales for Pumps and Pens for the Years 2024 & 2030
    • TABLE 62: Rest of World Recent Past, Current & Future Analysis for Smart Insulin Pens and Pumps by End-Use - Hospitals & Clinics, Home Care and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Rest of World 7-Year Perspective for Smart Insulin Pens and Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care and Laboratories for the Years 2024 & 2030

IV. COMPETITION